EA
CRL icon

Emerald Acquisition’s Charles River Laboratories CRL Stock Holding History

Emerald Acquisition’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$40.2M Buy
482,392
+33,359
+7% +$2.8M 0.08% 310
2016
Q2 		$37M Buy
+449,033
New +$37M 0.06% 354

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Emerald Acquisition's CRL Position: Q3 2016 in Review

Emerald Acquisition increased its Charles River Laboratories (CRL) stake by 7.4% in Q3 2016, buying an estimated $2.8M and bringing the position to 482,392 shares worth $40.2M. The position accounts for 0.08% of the portfolio, ranked #310.

Emerald Acquisition first reported a position in CRL in Q2 2016 and has held it in 2 quarters since. 283 funds tracked by Wall St. Rank hold CRL as of Q3 2016.

  • Emerald Acquisition held 482,392 shares of Charles River Laboratories worth $40.2M as of Q3 2016.
  • Emerald Acquisition bought 33,359 Charles River Laboratories shares in Q3 2016, an estimated $2.8M.
  • Charles River Laboratories made up 0.08% of Emerald Acquisition's portfolio in Q3 2016, its #310 holding.
  • Emerald Acquisition first reported a position in Charles River Laboratories in Q2 2016 and has held it in 2 quarters since.
  • 283 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.